Home » Topics » BioWorld

BioWorld
RSS

NIH PATENT CLAIMS MANY VARIATIONS

March 13, 1992

ANOTHER ALZHEIMER'S MODEL RETRACTED

March 13, 1992

FDA PANEL VOTES FOR CHIRON BLOOD TEST

March 13, 1992

SYNTHECELL TO ACQUIRE VEGA BIOTECH

March 13, 1992

METRA BOOSTS SECOND-ROUND STAKE

March 13, 1992

THERATECH FILES FOR IPO

March 12, 1992

ANERGEN COMPOUND QUELLS MUSCLE DISORDER IN RATS

March 12, 1992

ISIS DEAL TO DELIVER ANTISENSE WITH VICAL'S LIPIDS

March 12, 1992

ECOGEN ENTERS NEMATODE BUSINESS

March 12, 1992

DNAP'S MOVES IN TOMATO TECHNOLOGY

March 12, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...